NBC News: 5-year-old receives prosthetic hand from UC student engineers
Alice Kurylo was born with a smaller right hand than left, which made everyday movements more challenging. That’s when student engineers at the University of Cincinnati stepped in to create a pink mechanical hand. Now Alice can hold hands and can give high-fives.
UC student group EnableUC manufactures 3D-printed parts to create inexpensive custom prosthetics for children across the country. Watch Alice's pink hand in action in her interview on NBC Nightly News.
Additional EnableUC media coverage
- PBS: How a 3-D printed hand from UC gave a girl the gift of play
- USA Today: Students build 3-D printed prosthetic hands for kids
- NPR: The Latest Advancements In Technology Designed To Improve Lives Of Those Facing Physical Challenges
- Medical Plastics News: Student organization developing affordable 3-D printed prosthetics
- 3ders.org: Student group EnableUC working on 3-D printed 'Luke Skywalker' prosthetic hand
- WKRC: Girl throws out 1st pitch at Reds game with help of prosthetic hand made by UC students
- WLWT: 4-year-old girl receives prosthetic hand thanks to Cincinnati students
- The Cincinnati Enquirer: UC students build 3-D printed prosthetic hands for kids
Related Stories
UC grad and Honda employee helps race team win Indy 500
June 11, 2026
UC engineering graduate JP Suozzi helped driver Felix Rosenqvist win the Indianapolis 500 as a trackside engineer with Honda Racing. While on co-op with Meyer Shank Racing, Suozzi monitored Honda engine performance at the track, contributing to the closest finish in Indy 500 history.
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Nanofiber multidrug offers new strategy for glioblastoma
June 8, 2026
Science and medical outlets highlight multidrug nanofiber to treat glioblastoma developed by the University of Cincinnati and Johns Hopkins Medicine.